| Product NDC: | 63736-200 |
| Proprietary Name: | Anacin |
| Non Proprietary Name: | Asprin and Caffeine |
| Active Ingredient(s): | 40; 32 mg/1; mg/1 & nbsp; Asprin and Caffeine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63736-200 |
| Labeler Name: | Insight Pharmaceuticals |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part343 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20090625 |
| Package NDC: | 63736-200-92 |
| Package Description: | 125 POUCH in 1 BOX (63736-200-92) > 1 TABLET in 1 POUCH |
| NDC Code | 63736-200-92 |
| Proprietary Name | Anacin |
| Package Description | 125 POUCH in 1 BOX (63736-200-92) > 1 TABLET in 1 POUCH |
| Product NDC | 63736-200 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Asprin and Caffeine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090625 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Insight Pharmaceuticals |
| Substance Name | ASPIRIN; CAFFEINE |
| Strength Number | 40; 32 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |